4D Molecular Therapeutics Inc.
13F holders, Q4 2025 (December 31)1holders
$7.50avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding 4D Molecular Therapeutics Inc. in their 13F filings. The largest holder was Allworth Financial LP ($3K).
- Company
- 4D Molecular Therapeutics Inc.
- CUSIP
- 00351E104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3K |
| Exits | 0 | $0 |
Ownership 1 holders
| Allworth Financial LP | 0.00% | New | 404 | $3K |
"% of holder's portfolio" is 4D MOLECULAR THERAPEUTICS IN's weight in each manager's 13F, not the share of 4D Molecular Therapeutics Inc. the manager owns.